Insider Trading History of Prestrelski Steven


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Prestrelski Steven since year 2005. The trader's CIK number is 1744027. At the time of the last reporting, Prestrelski Steven was the Chief Scientific Officer of Xeris Pharmaceuticals Inc . (stock ticker symbol XERS). See this page for all insider trading activities at Xeris Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Prestrelski Steven since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2020-01-13 XERS Xeris Pharmaceuticals Inc Sale 10,000 5.50 54,990
2019-01-14 XERS Xeris Pharmaceuticals Inc Sale 7,700 17.20 132,463
2019-10-11 XERS Xeris Pharmaceuticals Inc Sale 10,000 7.97 79,750
2019-07-11 XERS Xeris Pharmaceuticals Inc Sale 10,000 12.37 123,690
2019-04-11 XERS Xeris Pharmaceuticals Inc Sale 10,000 9.56 95,650
2019-01-11 XERS Xeris Pharmaceuticals Inc Sale 2,300 .00 0
2018-12-26 XERS Xeris Pharmaceuticals Inc Sale 15,720 15.82 248,737
2018-12-24 XERS Xeris Pharmaceuticals Inc Option Ex 15,720 1.19 18,706

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Prestrelski Steven (Chief Scientific Officer of Xeris Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month